Globus Medical, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Medical - Devices |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Globus Medical, Inc. (GMED) holds an ST Score of 68.3 out of 100 (B+), with its strongest factor being Sentiment (A+) and its weakest Valuation (D). Analysts rate GMED Buy across 36 ratings with a $98.88 average price target (+0.3% vs the current $74.08).
- Strongest
- SentimentA+
- Weakest
- ValuationD
All factor grades
- SentimentA+
- ProfitabilityA
- Financial StrengthA
- GrowthB+
- ForecastB-
- MomentumC+
- ValuationD
- Piotroski7/9
Contact
GMED stock: frequently asked questions
What is GMED's ST Score?
Globus Medical, Inc. (GMED) has an ST Score of 68.3 out of 100, an overall grade of B+. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is GMED a buy, sell, or hold?
Wall Street's consensus rating on GMED is Buy based on 36 analyst ratings. Our own ST Score grades it B+ (68.3/100). This is data, not investment advice — always do your own research.
What is GMED's valuation grade?
Globus Medical, Inc. (GMED) earns a valuation grade of D, measured against Medical - Devices peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is GMED's growth grade?
Globus Medical, Inc. (GMED) earns a growth grade of B+, measured against Medical - Devices peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is GMED's profitability grade?
Globus Medical, Inc. (GMED) earns a profitability grade of A, measured against Medical - Devices peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is GMED's financial strength grade?
Globus Medical, Inc. (GMED) earns a financial strength grade of A, measured against Medical - Devices peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for GMED?
The average analyst price target for Globus Medical, Inc. (GMED) is $98.88 from 36 analysts, which is +0.3% versus the recent price of $74.08.
What is GMED's Piotroski score?
Globus Medical, Inc. (GMED) has a Piotroski F-Score of 7 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.